Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)DivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BridgeBio Pharma (BBIO) Other Working Capital Changes: 2019-2025

Historic Other Working Capital Changes for BridgeBio Pharma (BBIO) over the last 7 years, with Sep 2025 value amounting to -$5.2 million.

  • BridgeBio Pharma's Other Working Capital Changes fell 214.15% to -$5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.8 million, marking a year-over-year decrease of 3.95%. This contributed to the annual value of $21.9 million for FY2024, which is 502.26% up from last year.
  • As of Q3 2025, BridgeBio Pharma's Other Working Capital Changes stood at -$5.2 million, which was down 120.61% from $25.3 million recorded in Q2 2025.
  • In the past 5 years, BridgeBio Pharma's Other Working Capital Changes registered a high of $25.3 million during Q2 2025, and its lowest value of -$7.9 million during Q1 2022.
  • Its 3-year average for Other Working Capital Changes is $3.1 million, with a median of -$1.3 million in 2023.
  • Per our database at Business Quant, BridgeBio Pharma's Other Working Capital Changes surged by 6,392.82% in 2022 and then tumbled by 490.24% in 2023.
  • BridgeBio Pharma's Other Working Capital Changes (Quarterly) stood at $886,000 in 2021, then slumped by 292.66% to -$1.7 million in 2022, then spiked by 42.94% to -$974,000 in 2023, then skyrocketed by 233.47% to $1.3 million in 2024, then slumped by 214.15% to -$5.2 million in 2025.
  • Its Other Working Capital Changes was -$5.2 million in Q3 2025, compared to $25.3 million in Q2 2025 and -$2.6 million in Q1 2025.